Ashapura Minechem Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 7, 2025, 12:05 pm

Quick Insight

Ashapura Minechem Ltd, trading at ₹534 with a market capitalization of ₹5,100 crore, presents a compelling investment case, particularly given its robust return metrics—ROE at 26.6% and ROCE at 17.1%. With a P/E ratio of 17.7, the stock appears reasonably valued within the mining sector, especially considering its operating profit margin of 15%. The company’s net profit of ₹289 crore, coupled with reserves of ₹1,223 crore against borrowings of ₹1,163 crore, indicates a healthy balance sheet. Furthermore, a current ratio of 4.42x suggests strong liquidity, while a cash conversion cycle of just 13 days enhances operational efficiency. With 47.70% promoter holding and significant institutional interest, Ashapura Minechem is well-positioned for growth, making it a potential buy for investors looking for stability and returns in the mining sector.

Competitors of Ashapura Minechem Ltd

All Competitor Stocks of Ashapura Minechem Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:47 am

Below is a detailed analysis of the quarterly data for Ashapura Minechem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 555.00 Cr.. The value appears to be declining and may need further review. It has decreased from 865.00 Cr. (Dec 2024) to 555.00 Cr., marking a decrease of 310.00 Cr..
• For Expenses, as of Mar 2025, the value is 471.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 731.00 Cr. (Dec 2024) to 471.00 Cr., marking a decrease of 260.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Dec 2024) to 84.00 Cr., marking a decrease of 51.00 Cr..
• For OPM %, as of Mar 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Dec 2024) to 15.00%, marking a decrease of 1.00%.
• For Other Income, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 56.00 Cr., marking an increase of 42.00 Cr..
• For Interest, as of Mar 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.00 Cr. (Dec 2024) to 30.00 Cr., marking an increase of 7.00 Cr..
• For Depreciation, as of Mar 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Dec 2024) to 29.00 Cr., marking an increase of 17.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Dec 2024) to 82.00 Cr., marking a decrease of 31.00 Cr..
• For Tax %, as of Mar 2025, the value is 7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 11.00% (Dec 2024) to 7.00%, marking a decrease of 4.00%.
• For Net Profit, as of Mar 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 108.00 Cr. (Dec 2024) to 79.00 Cr., marking a decrease of 29.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 9.05. The value appears to be declining and may need further review. It has decreased from 11.04 (Dec 2024) to 9.05, marking a decrease of 1.99.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 6:05 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:28 pm

Below is a detailed analysis of the balance sheet data for Ashapura Minechem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 912.00 Cr. (Mar 2024) to 1,223.00 Cr., marking an increase of 311.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,163.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 984.00 Cr. (Mar 2024) to 1,163.00 Cr., marking an increase of 179.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,526.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,397.00 Cr. (Mar 2024) to 1,526.00 Cr., marking an increase of 129.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,931.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,311.00 Cr. (Mar 2024) to 3,931.00 Cr., marking an increase of 620.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,349.00 Cr.. The value appears strong and on an upward trend. It has increased from 577.00 Cr. (Mar 2024) to 1,349.00 Cr., marking an increase of 772.00 Cr..
• For CWIP, as of Mar 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 504.00 Cr. (Mar 2024) to 55.00 Cr., marking a decrease of 449.00 Cr..
• For Investments, as of Mar 2025, the value is 344.00 Cr.. The value appears strong and on an upward trend. It has increased from 321.00 Cr. (Mar 2024) to 344.00 Cr., marking an increase of 23.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,181.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,909.00 Cr. (Mar 2024) to 2,181.00 Cr., marking an increase of 272.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,931.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,311.00 Cr. (Mar 2024) to 3,931.00 Cr., marking an increase of 620.00 Cr..

Notably, the Reserves (1,223.00 Cr.) exceed the Borrowings (1,163.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Ashapura Minechem Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 31.37. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 31.37, marking an increase of 18.58.
• For Diluted EPS (Rs.), as of Mar 24, the value is 30.50. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 30.50, marking an increase of 17.71.
• For Cash EPS (Rs.), as of Mar 24, the value is 33.85. This value is within the healthy range. It has increased from 18.00 (Mar 23) to 33.85, marking an increase of 15.85.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.26. It has increased from 71.84 (Mar 23) to 100.26, marking an increase of 28.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 100.26. It has increased from 71.84 (Mar 23) to 100.26, marking an increase of 28.42.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 290.08. It has increased from 200.12 (Mar 23) to 290.08, marking an increase of 89.96.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 33.66. This value is within the healthy range. It has increased from 28.28 (Mar 23) to 33.66, marking an increase of 5.38.
• For PBIT / Share (Rs.), as of Mar 24, the value is 25.07. This value is within the healthy range. It has increased from 20.34 (Mar 23) to 25.07, marking an increase of 4.73.
• For PBT / Share (Rs.), as of Mar 24, the value is 28.21. This value is within the healthy range. It has increased from 13.31 (Mar 23) to 28.21, marking an increase of 14.90.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 25.26. This value is within the healthy range. It has increased from 10.06 (Mar 23) to 25.26, marking an increase of 15.20.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 31.37. This value is within the healthy range. It has increased from 12.79 (Mar 23) to 31.37, marking an increase of 18.58.
• For PBDIT Margin (%), as of Mar 24, the value is 11.60. This value is within the healthy range. It has decreased from 14.12 (Mar 23) to 11.60, marking a decrease of 2.52.
• For PBIT Margin (%), as of Mar 24, the value is 8.64. This value is below the healthy minimum of 10. It has decreased from 10.16 (Mar 23) to 8.64, marking a decrease of 1.52.
• For PBT Margin (%), as of Mar 24, the value is 9.72. This value is below the healthy minimum of 10. It has increased from 6.65 (Mar 23) to 9.72, marking an increase of 3.07.
• For Net Profit Margin (%), as of Mar 24, the value is 8.70. This value is within the healthy range. It has increased from 5.02 (Mar 23) to 8.70, marking an increase of 3.68.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.81. This value is within the healthy range. It has increased from 6.39 (Mar 23) to 10.81, marking an increase of 4.42.
• For Return on Networth / Equity (%), as of Mar 24, the value is 30.85. This value is within the healthy range. It has increased from 17.60 (Mar 23) to 30.85, marking an increase of 13.25.
• For Return on Capital Employeed (%), as of Mar 24, the value is 12.97. This value is within the healthy range. It has increased from 11.50 (Mar 23) to 12.97, marking an increase of 1.47.
• For Return On Assets (%), as of Mar 24, the value is 8.66. This value is within the healthy range. It has increased from 3.83 (Mar 23) to 8.66, marking an increase of 4.83.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.73. This value is within the healthy range. It has decreased from 0.97 (Mar 23) to 0.73, marking a decrease of 0.24.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.14 (Mar 23) to 1.06, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.83. It has increased from 0.66 (Mar 23) to 0.83, marking an increase of 0.17.
• For Current Ratio (X), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.28 (Mar 23) to 1.19, marking a decrease of 0.09.
• For Quick Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 23) to 0.85, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 4. It has decreased from 0.94 (Mar 23) to 0.71, marking a decrease of 0.23.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.42. This value is within the healthy range. It has increased from 4.02 (Mar 23) to 4.42, marking an increase of 0.40.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.90. This value is below the healthy minimum of 3. It has increased from 2.43 (Mar 23) to 2.90, marking an increase of 0.47.
• For Enterprise Value (Cr.), as of Mar 24, the value is 4,259.26. It has increased from 1,694.73 (Mar 23) to 4,259.26, marking an increase of 2,564.53.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 0.92 (Mar 23) to 1.60, marking an increase of 0.68.
• For EV / EBITDA (X), as of Mar 24, the value is 13.83. This value is within the healthy range. It has increased from 6.55 (Mar 23) to 13.83, marking an increase of 7.28.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.29. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.29, marking an increase of 0.74.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 3.69. This value exceeds the healthy maximum of 3. It has increased from 1.54 (Mar 23) to 3.69, marking an increase of 2.15.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.29. This value is within the healthy range. It has increased from 0.55 (Mar 23) to 1.29, marking an increase of 0.74.
• For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to 0.08, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness